Signal strength and signal duration define two distinct aspects of JNK-regulated axon stability  by Rallis, Andrew et al.
Developmental Biology 339 (2010) 65–77
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logySignal strength and signal duration deﬁne two distinct aspects of JNK-regulated
axon stability
Andrew Rallis, Coralie Moore, Julian Ng ⁎
MRC Centre for Developmental Neurobiology, New Hunt's House, Guy's Campus, King's College, London SE1 1UL, UK⁎ Corresponding author.
E-mail address: julian.ng@kcl.ac.uk (J. Ng).
0012-1606 © 2009 Elsevier Inc.
doi:10.1016/j.ydbio.2009.12.016
Open access under CC BYa b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 16 September 2009
Revised 10 December 2009
Accepted 11 December 2009









DrosophilaSignaling proteins often control multiple aspects of cell morphogenesis. Yet the mechanisms that govern
their pleiotropic behavior are often unclear. Here we show activity levels and timing mechanisms determine
distinct aspects of Jun N-terminal kinase (JNK) pathway dependent axonal morphogenesis in Drosophila
mushroom body (MB) neurons. In the complete absence of Drosophila JNK (Basket), MB axons fail to
stabilize, leading to their subsequent degeneration. However, with a partial loss of Basket (Bsk), or of one of
the upstream JNK kinases, Hemipterous or Mkk4, these axons overextend. This suggests that Bsk activity
prevents axons from destabilizing, resulting in degeneration and overextension beyond their terminal
targets. These distinct phenotypes require different threshold activities involving the convergent action of
two distinct JNK kinases. We show that sustained Bsk signals are essential throughout development and act
additively but are dispensable at adulthood. We also suggest that graded Bsk inputs are translated into AP-1
transcriptional outputs consisting of Fos and Jun proteins. license.© 2009 Elsevier Inc. Open access under CC BY license.Introduction
To reach maturity, developing neurons undergo many morphoge-
netic changes including axon and dendrite formation/polarity, neurite
extension, guidance, branching and synaptogenesis. The mechanisms
that underlie these distinct steps are not well understood. This results
partly from the observation that, although many molecules are
involved, they exhibit pleiotropy, controlling several aspects of
neuronal morphogenesis. The MAPK family of signaling proteins
epitomizes such pleiotropic factors. They are present throughout
eukaryotes and control many cellular responses, such as proliferation,
differentiation, stress and apoptotic control (Weston andDavis, 2002).
MAPKs (Erk, JNK or p38 members) are activated through phospho-
rylation by upstreamkinases,which are themselves regulated by other
protein kinases. Several studies show the Jun N-terminal kinase (JNK)
pathway is involved in axon formation/polarization, extension,
synaptic plasticity and dendrite development (Oliva et al., 2006;
Rosso et al., 2005; Sanyal et al., 2002; Srahna et al., 2006). Many non-
neuronal models have been used to explain how JNKs regulate
multiple aspects of cell regulation. For example, one proposal is that
the core-signaling component is linked to distinct specialized com-
plexes. JNKs are regulated by distinct upstream kinases through
interactions with scaffold proteins (Weston and Davis, 2002). Theselink JNK responses to particular stimuli, such as morphogenetic, stress
or apoptotic regulation. However, timing mechanisms can also play a
role. From chemical genetic paradigms using JNK mutant mice,
transient or prolonged JNK inactivation can affect distinct JNK-
dependent immune responses (Ventura et al., 2006). Another
possibility is that signaling molecules have context-dependent roles
in different cell types. Thus, while in mammalian hippocampal cells,
JNKs are involved in dendritogenesis (Rosso et al., 2005) and axonal
polarity/formation (Oliva et al., 2006), in Drosophila dorsal cluster
(DC) neurons, JNK is involved in axon extension (Srahna et al., 2006),
and at the Drosophila neuromuscular junction (NMJ), JNK regulates
synaptic plasticity and growth (Collins et al., 2006; Sanyal et al., 2002).
In Drosophila, the JNK signaling network consists of one JNK,
Basket (Bsk), which is regulated by two JNK kinases (JNKKs),
Hemipterous (Hep) and MAP kinase kinase 4 (MKK4) (Glise et al.,
1995; Han et al., 1998; Riesgo-Escovar and Hafen, 1997b). Six JNKK
kinases (JNKKKs) exist, which control the JNKKs (Stronach, 2005).
Further upstream, a single JNKKKK, Misshapen (Msn), regulates the
JNKKKs (Su et al., 1998). Like in many other model systems studied,
Bsk responses in Drosophila are varied. While ﬁrst shown to control
epithelial morphogenesis during embryonic dorsal closure, Bsk also
contributes to imaginal disk development, apoptotic regulation,
wound healing, tissue regeneration, tissue homeostasis and innate
immunity (Agnes et al., 1999; Bosch et al., 2005; Delaney et al., 2006;
Galko and Krasnow, 2004; Mattila et al., 2005; Noselli, 1998; Pastor-
Pareja et al., 2004; Ramet et al., 2002; Ryoo et al., 2004; Sluss et al.,
1996; Vidal et al., 2001; Zeitlinger et al., 1997). Additionally, Bsk
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ﬂies (Wang et al., 2003).
In many of these responses, Bsk targets the phosphorylation of the
Activator protein-1 (AP-1) complex, composed of the transcriptionfactors Fos and Jun (Ciapponi et al., 2001; Kockel et al., 1997). In
Drosophila, these act either as heterodimers or as Fos homodimers
(Pearson et al., 2009; Perkins et al., 1990). In many studies, distinct
JNKKKs are thought to represent stimulus-speciﬁc regulators and the
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(Stronach, 2005). The in vivo role of MKK4 has not been previously
described.
Here we show that Drosophila JNK controls two distinct axonal
phenotypes inmushroom body (MB) neurons. Depending on the level
of Bsk inactivation, this results in a bias towards axon degeneration or
overextension. Based on these phenotypes, we propose that Bsk
controls axon stabilization via twomechanisms, to prevent axons from
degenerating and from overextending beyond the postsynaptic target.
These mechanisms require different threshold activity levels, involv-
ing the upstream JNKKs, Hep and Mkk4. We show that sustained Bsk
activity is required throughout development to maintain axonal
stability. These phenotypes are mediated through AP-1, which
shows a similar graded response to these axonal phenotypes.
Materials and methods
Drosophila strains
bsk147eand hep mutant strains (hepR39and hep75) are null muta-
tions, as previously described (Glise et al., 1995; Sluss et al., 1996). The
bskH15 allele (Berger et al., 2008) encodes amissensemutation (I212F-
PB isoform) within the kinase domain, which is likely to result in a
hypomorphic allele (see quantiﬁcations in Fig. 6I) The Mkk4e01458
allele is derived from a PiggyBac insertion (Thibault et al., 2004).
Mkk4e01458complemented the lethality associated with chromosomal
deﬁciencies Df(3R)Dhod15, Df(3R)BSC195 and Df(3R)BSC197 but
failed to complement Df(3R)p13 and Df(3R)Exel6149 (Flybase).
Ubiquitous expression of Mkk4 (tub-GAL4NMKK4YFP) fully rescued
the lethality associated with Mkk4e01458/Df(3R)p13 transhetero-
zygotes, conﬁrming that the insertion disrupts the Mkk4 locus.
The following additional strains were also used in our study; UAS-
Bskmyc, UAS-Mkk4Venus (this study); UAS-Bsk RNAi, UAS-Mkk4 RNAi
(VDRC lines 34138, 34139 and 26928), UAS-Dcr2 (Dietzl et al., 2007);
UAS-Bsk DN, UAS-Hep.B2, UAS-Hep.CA4 and GAL80ts7 (Bloomington
Drosophila Stock Center); Jun2, Jun1 (Kockel et al., 1997); UAS-Jbz,
UAS-Fbz, (Eresh et al., 1997); UAS-kay RNAi, UAS-hep RNAi (NIG-Fly,
Mishima; lines 15507R-4 and 2190R-1); kay1(Riesgo-Escovar and
Hafen, 1997a; Zeitlinger et al., 1997); kayED6315 (Weber et al., 2008).
These kay alleles are not true nulls, as they do not disrupt all Kay
isoforms (Giesen et al., 2003; Weber et al., 2008). Drosophila strains
for MARCM analysis have previously been described (Lee and Luo,
1999) and mutant strains were generated by standard recombination
techniques.
Molecular biology
To generate expression vectors pUAST-Bskmyc and pUAST-
Mkk4YFP, Bsk and Mkk4 cDNAs (a gift from D. Bohmann and BDGP
clone RE70055, respectively) were cloned into a pENTR vector
(Invitrogen) by PCR and TOPO® cloning. The resulting pENTR-Bsk
and pENTR-Mkk4 clones were ligated to the destination vectors
(pTWM or pTWV, respectively; T. Murphy, Carnegie Drosophila
Gateway® vectors) using the Gateway® system (Invitrogen). pUAST-
BskMycT181A, Y183F was constructed by site directed mutagenesis
(Quikchange®, Stratagene) and cloning into the pTWM vector, as
above. Germline transformations were performed commercially
(Aktogen, Cambridge, UK).Fig. 1. JNK is highly expressed in MB axons and dendrites. (A) MB axons labeled by CD8-GF
type. Axons terminate close to the midline (to the right of all images, unless indicated with
different axon lobes (γ, α'β', αβ) are indicated, as previously (Lee et al., 1999). (A') A schem
dendrite (‘calyx’) and axon projections. (B) The same brain immunostained with anti-JNK1, t
brain also immunostained with anti-phospho JNK (P-JNK). (C') The overlap shows high JNK
wandering larvae L3 and pupae at different time-points after puparium formation (APF),
between P-JNK and the GFP labeled MB axons at these stages. Unless indicated otherwise, the
In some images (such as in A), cell body sections have been omitted to clearly reveal axonaGeneration of MARCM clones, UAS-Gal4, RNAi and TARGET expression
analysis
Homozygous mutant clones that are positively labeled were
generated using the MARCM method. MB neuroblast and single-cell
clones were generated as previously described (Wu and Luo, 2006b).
A single neuroblast clone can give rise to ∼600 Kenyon cells (Ito et al.,
1997). Neurons were visualized using the OK107-Gal4 driver
expressing mCD8GFP. The Gal4-OK107 driver was also used in
misexpression studies, along with one copy of UAS-CD8GFP. Flies
were reared at 25 °C, unless otherwise stated such as in RNAi and
TARGET experiments. For ‘high’ level of RNAi knockdown, ﬂies were
cultured at 29 °C in the presence of ectopic Dicer (Dcr2), to increase
the level of UAS expression and RNAi efﬁciency (Dietzl et al., 2007).
For ‘medium’ RNAi activity, ﬂies were raised at 29 °C without ectopic
Dcr2. We found that even at low levels of RNAi expression (18 °C),
Dcr2 expression can signiﬁcantly enhance RNAi phenotypes. Ectopic
expression of Dcr2 alone does not disrupt MB axon projections (data
not shown). Flies were dissected within 3–7 days post-eclosion. For
the TARGET protocol, ﬂies were grown at 18 °C and UAS-GAL4
expression was induced by transferring to 29 °C at the indicated
stages. In the ‘reverse’ protocol, ﬂies were grown at 29 °C and shifted
to 18 °C. These ﬂies were maintained in the shifted temperatures and
analyzed at 3 days post-eclosion, unless indicated otherwise.
Immunohistochemistry
Fly brains were dissected at various stages and stained as
previously described (Wu and Luo, 2006a). For MARCM neuroblast
and single-cell clones, axon projections were visualized using anti-
FasII (1:5) and anti-mCD8, 1:200. The following additional antibodies
were used: anti-JNK1 (Santa Cruz Biotechnology, sc-571, 1:250), anti-
phospho JNK (Cell Signalling, no. 9255, 1:250), anti-Myc (Santa Cruz
Biotechnology, clone 9E10; 1:100 or Cell Signalling, no. 2272; 1:200),
anti-GFP (Molecular Probes, A11122, 1:100 or Roche, 11814460001,
1:200), anti-MKK4 (1:50) and anti-Hep (1:100). Anti-Hep and anti-
Mkk4 antibodies were generated commercially using rabbit and
guinea pig hosts, respectively, using a DXP protocol (Eurogentec,
Seraing, Belgium). The following peptide sequences were used as
immunogens (QSLEAKLQAQNESHDC and CLRANGDPTLQRLPNS for
Hep; MAERPKNLFATGSSRC and CKDGITQFTANQQAES for Mkk4).
Stained brains were imaged by confocal microscopy (using Zeiss
510 and processed using Zeiss LSM and Adobe photoshop software).
S2 cell culture, expression and Western blotting analysis
Drosophila S2 cells were maintained at 25 °C in Schneider's media,
supplemented with 10% fetal bovine serum. S2 transfections were
performed using the pMT-GAL4 binary system (Klueg et al., 2002).
Brieﬂy, 2×106 cells (50% conﬂuent) were plated in 2 ml of medium
24 h prior to the transfection. 2 μg of pUAST and 2 μg of pMT-GAL4
plasmids were then added per well (90% cell conﬂuent stage), along
with 30 μl of Cellfectin (Invitrogen) in 2 ml of antibiotic-free,
Schneider's Media. The media were removed 3 h post-transfection
and replaced with media supplemented with 10% fetal bovine serum,
1% streptomycin (Gibco BRL). Twelve hours later, the media were
replaced with media containing 1% CuSO4 to induce protein
expression. S2 cells were subsequently harvested 24 h later. CellsP expression, using the OK107-Gal4 driver. These adult MB axonal projections are wild
a dashed white line), or close to the anterior dorsal cortex (dashed orange line). The
atic of these MB neuron subtypes (γ, α'β', αβ) and the relative location of cell bodies,
he overlap with the GFPmarker (magenta in B') shows axonal localization. (C) The same
activity in MB axons. (D–I) P-JNK brain staining at various developmental stages, from
indicated in hours (h). The additional panels (D'–I') show the corresponding overlap
se and subsequent images are z-stack of serial confocal images taken at 1-μm thickness.
l projections. Scale bar: 20 μm.
Fig. 2. JNK loss results in axon destabilization. (A, A') Adult MB bsk147eneuroblast clones show axon thinning (yellow arrow) and termination defects (open white arrowheads). (B–I)
Images of CD8-GFP labeled wild-type (B–E) and bsk147e (F–I) neuroblast clones analyzed at developmental stages: 0 h (B, F), 24 h (C, G), 48 h (D, H) and 72 h APF (E, I). At the onset of
puparium formation (0 h APF), the majority of wild-type MB neurons consist of γ andα'β' neurons (B). A phase of neurogenesis occurs at this period andMB neuroblasts give rise to
αβ neurons, which are visible at 24 h APF (C). As axon continue to grow, dorsal α and medial β lobes become more prominent. At 48 h APF, these lobes are similar to adult MB
projections (D compare with Fig. 1A, respectively). Note bsk axonal defects at later stages of development (quantiﬁed in N). Axon defects were also more pronounced at later stages
(compare H to I). The cell body section has been omitted from I. (J–L) Images of bsk147e single cell clones (γ-neurons) showing breaks (yellow arrowheads) along different regions of
the axon. (J', K and L) Higher magniﬁcation of MB axons shows breaks and axon thinning in the proximal and mid-axonal shaft (J',K, respectively) and in the distal section (L). Scale
bars: 20 μm. Unless indicated otherwise, CD8-GFP labeled neurons are shown in green or grayscale and Fas2 immunostaining (magenta) labels a subset (γweakly and αβ strongly)
of all MB axons. (M–N) Quantiﬁcation of β-axon termination defects in adult MB bsk147e neuroblast clones (M), and at speciﬁc time points in development (N). n, number of
neuroblast clones analyzed. While all MB axons displayed degeneration phenotypes to some extent, to simplify this study, we decided to focus on the medially projecting β-lobe. For
bsk additional images and quantiﬁcations of other MB projections, see Supplementary Fig. 2.
68 A. Rallis et al. / Developmental Biology 339 (2010) 65–77were harvested by centrifugation at 1000 g for 5 min and lysed on ice
for 30 min in RIPA buffer [10 mM Tris (pH 7.4), 10 mM NaH2PO4,
150 mM NaCl, 1% Triton X-100], supplemented with protease and
phosphatase inhibitors (Halt® protease inhibitor from Pierce, 10 mMNaF and 1mMNa3VO4). Lysates were spun for 10 min at 21,000 g. The
supernatant was added to reducing sample loading buffer (2) in equal
quantity. Reduced protein samples were run on 10% polyacrylamide
Tris–HCl gels and transferred to Invitrolon®membranes (Invitrogen),
Fig. 3. JNK phosphorylation is essential for axonal morphogenesis. (A, B) bsk147e
neuroblast clones in the presence of Bsk mTPY (A), or wild-type Bsk (B). Wild-type Bsk,
but not BskmTPY, expression rescues the axon phenotype. Cell body sections have been
omitted in both panels. Scale bars: 20 μm. Green, CD8-GFP. Magenta, Fas2.
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phospho-JNK (Cell Signalling, no. 9255, 1:1000) and JNK1 (Santa Cruz
Biotechnology, sc-571, 1:4000), Hep (ab1956; 1:2000 and ab1957;
1:250) and Mkk4 antibodies (ab1954 and 1955; both at 1:5000).
Additional antibodies used were GFP (Molecular Probes, A11122,
1:4000) and myc (Santa Cruz Biotechnology, clone 9E10, 1:4000)
using standard protocols. Blots were developed with Pico-ECL
chemiluminescence reagents (Pierce) and exposed to ECL hyperﬁlm
(Amersham Biosciences).
Results
Drosophila JNK activity is detected in MB axons
MB neurons (Kenyon cells) in the Drosophila brain were used as
a model to analyze Bsk signaling in vivo (Ito et al., 1997; Kurusu
et al., 2002; Lee et al., 1999). Adult MB neurons are composed of
three distinct sets (γ, α'β' and αβ) with each set having distinct
axonal projections (Lee et al., 1999)(Figs. 1A and A'). MB axons
extend from posterior located cell bodies and lead to dorsal and
medial projections in the anterior part of the brain. These
projections terminate in the anterior dorsal cortex (α' and α), or
close to the midline (γ, β' and β). Antibodies were used in whole-
mount immunohistochemistry to determine Bsk activity in these
neurons. Using a human JNK1 antibody that cross-reacts with the
Drosophila protein, Bsk was detected in MB axons (Fig. 1B). Using
a phosphorylation-speciﬁc antibody that detects active forms of JNK,
we found that Bsk was highly phosphorylated in adult MB axons
(Fig. 1C). Low Bsk and p-Bsk signals were also present throughout
the brain. Other notable structures that showed high Bsk/p-Bsk
signals included the antennal lobe (AL) and ellipsoid body (eb)
regions (Supplementary Fig. 1). As antibody controls, JNK and
phospho-JNK immunoreactivity were not present when Bsk was lost
or when its activity was inhibited in MB neurons (Supplementary
Fig. 1). Analysis at different developmental stages showed that Bsk is
active in axons throughout development, from wandering L3 larvae
to adulthood (Fig. 1).
Bsk loss results in axon degeneration
The effect of Bsk inactivation was determined by generating
MARCM neuroblast clones in MB neurons (see Methods). Analyzed
at the adult stage, most bsk-null axons failed to reach the wild-type
termination point (Figs. 2A, A', arrows). Many bsk clones also
showed discontinuous thinning along the axon tracts, suggesting a
possible axon loss (yellow arrow in Fig. 2A'). Interestingly, a
minority of bsk axons displayed the converse phenotype with axon
overextensions beyond their normal termination points (Supple-
mentary Fig. 2A, B, open white arrows; quantiﬁcations in Fig. 2M
and Supplementary Fig. 2I).
To determine whether this phenotype resulted from a failure in
axon extension or stabilization, leading to subsequent degeneration,
we analyzed bsk clones at different stages of development. The
results showed the majority of bsk axons had normal, wild-type
projections at early stages, but axonal defects characteristic of the
adult stage were observed from 30 h after puparium formation (APF)
onwards (Figs. 2F–I compared to wild type, Figs. 2B–E; quantiﬁed in
Fig. 2N). These axon defects were often subtle at early to mid-pupal
stages (data not shown; Fig. 2H) but becomes more acute in late
pupae (Fig. 2I). At the adult stages, the entire axon lobe is often
missing (Fig. 2A').
We analyzed this further by generating bsk single-cell clones. We
found many fully extended axons showed thinning and breaks
(Figs. 2J–L; compared to wild-type images in Supplementary Fig.
2C–E). This was not conﬁned to axons, but also found in the mainprocess close to the cell body, indicating an overall degeneration was
taking place (Supplementary Fig. 2F, G compared towild type, Fig. 2H).
This was statistically signiﬁcant when compared to wild-type clones
for all axon regions analyzed (Supplementary Fig. 2J). We found that
Bsk inactivation also resulted in many changes in the axonal
architecture, with the increased presence of large protrusions and
swellings (Supplementary Fig. 2B compared to wild type, Fig. 2C–E).
Together these results strongly suggest that Bsk loss does not result in
an initial defect of axon extension but in the subsequent failure in axon
stabilization, leading to neurodegeneration and axon loss.
Bsk phosphorylation is essential for axonal morphogenesis
Bsk is activated by phosphorylation by the JNKKs, Hep and MKK4,
on two predicted residues on threonine 181 and tyrosine 183 (Glise
et al., 1995; Han et al., 1998). We ﬁrst determined the relevance of
these sites by generating a Bsk mutant that removes the phospho-
acceptor sites (Bsk T181A, Y183F, or Bsk mTPY). By Western blotting,
the phospho-JNK antibody does not detect Bsk mTPY (Supplementary
Fig. 3A). Interestingly, overexpression of Bsk mTPY partially mimics
the dominant negative (DN) Bsk misexpression phenotype when
expressed in wild-type MB neurons (Supplementary Fig. 3B; see
below). We determined whether Bsk mTPY expression would rescue
the bsk phenotype. The results show, in contrast to the wild-type Bsk,
Bsk mTPY expression failed to rescue the bsk axonal phenotypes, not
only in MB neurons but also in optic lobe contralateral projecting (OL)
neurons where bsk axon extension phenotypes were also observed
(Fig. 3 and Supplementary Fig. 3, respectively; quantiﬁed in
Supplementary Fig. 3G). These results show phosphorylation of
these residues are critical for axonal morphogenesis and that the
phospho-JNK antibody serves as a valid marker of Bsk activity in these
neurons.
Role of the Drosophila JNKK Hep in axonal morphogenesis
Given the importance of JNK phosphorylation, we next determined
the expression pattern of the JNKK, Hep. Hep antibodies were
generated and used in western blotting (Supplementary Fig. 4A)
and immunohistochemistry (Figs. 4A–C, G). Hep was detected in all
MB axons but was less prominent in the cell bodies (Figs. 4A–C).
Additional Hep signals were also observed throughout the brain,
including the AL. By UAS-Hep expression, ectopic Hep staining also
showed preferential localization to MB axons (Fig. 4G).
The role of Hep was determined by loss-of-function analysis. In
hep-null clones, while axon degeneration was detected, it was not
the major phenotype (Figs. 5A, I). Instead, axon overextensions were
mainly observed (Figs. 5B, I). This is surprising, given that Hep is
consistently described as a central regulator of Bsk (Stronach, 2005),
hep-null clones might be expected to phenocopy bsk phenotypes to
the same extent (Fig. 2M).
Fig. 4. Expression study of JNK kinases Hep and MKK4. (A–F ') Single confocal sections of MB neurons labeled with CD8-GFP and immunostained with Hep (A–C') or Mkk4 (D–F')
antibodies. The corresponding panels (A'–F') show overlap between Hep and Mkk4 signals and CD8-GFP labeling. Single sections show γ (A, D), α/β and α'/β' axons (B, E) and MB
cell bodies (cb) (C, F), as indicated in A'–C'. (G–G) CD8-GFP labeled MB neurons (green) expressing ectopic Hep (shown in magenta in G and G' and grayscale in G). Dorsal (y)
projection views (G' and G) show Hep is mainly localized to axons (ax). (H–H) Representative image of MB neurons expressing MKK4YFP (green) and stained with anti-MKK4
(magenta in H and H' and white in H). Dorsal views (H' and H) show MKK4 is localized to axons and cell bodies (cb). Scale bar: 20 μm (x-only).
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Another JNKK regulator of Bsk is MKK4 (Han et al., 1998).
Antibodies to Mkk4 were generated and used in Western blotting
and immunohistochemistry (Supplementary Fig. 4B; Figs. 4D–F).
Mkk4 was detected in MB axons (particularly in α'β' and αβ axons)
and cell bodies (Figs. 4D, E and F, respectively). This was conﬁrmed by
the expression of Mkk4-YFP fusion protein in these neurons (Fig. 4H).
Using a recently described MKK4 mutant allele (Thibault et al., 2004)
(seeMethods), we generatedMKK4e01485MB clones. This also resulted
in axon overextension (Fig. 5C), although this phenotype was less
frequently observed than in hep clones (Fig. 5I). Cell proliferationdefects were also observed in neuroblasts derived from earlier-born
MKK4e01485clones (Fig. 5D). This is consistent with recent reports,
which show MKK4 loss results in cytokinetic defects in cultured
Drosophila S2 cells (Bettencourt-Dias et al., 2004; Bjorklund et al.,
2006).
Given the similar axon overextension phenotypes, we tested
whether Hep and MKK4 are interchangeable. Ectopic Mkk4 was
expressed in hep clones andMkk4 clones were generated with ectopic
Hep. hep phenotypes were not suppressed by ectopic Mkk4, but the
loss of Mkk4 can be rescued by increased Hep (Figs. 5E and G,
respectively). In control experiments, these same UAS lines could
rescue the corresponding hep or Mkk4 phenotypes (Figs. 5F and H,
71A. Rallis et al. / Developmental Biology 339 (2010) 65–77respectively; quantiﬁed in Fig. 5I). These results suggest that while
both JNKKs regulate axon growth, Hep plays a more prominent role in
these axons (see also Supplementary Fig. 5).
Partial inactivation of Bsk results in axon overextension
As loss of either JNKK results in the same phenotype, one
explanation is that partial Bsk inactivity leads to a bias towards
axon overextension. To test this, two strategies were used to partially
reduce Bsk signals in MB neurons. Given the high level of Bsk in these
neurons, we reasoned that either RNAi or DN Bsk misexpression are
unlikely to result in a null, but a partial inactivation phenotype. Bsk
RNAi or DN Bsk expression in all MB neurons resulted in a number of
axon defects, with defasciculation, degeneration and overextension
phenotypes (Figs. 6A–C). Notably, while Bsk RNAi expression resulted
in many degenerating axons, axon overextension was also observed,
particularly at lower titres of RNAi activity (Figs. 6A, B, respectively;
quantiﬁed in Fig. 6D and Supplementary Fig. 6A; see Methods). Axon
overextensions were also observed by DN Bsk misexpression, and this
constituted the major phenotype observed (Figs. 6C, D). Therefore,
distinct from the bsk-null phenotype where axon degeneration
predominates, these results suggest that a partial loss of Bsk leads
to axon overextension.
These results, together with the JNKK study, make two further
predictions: that concomitant loss of Hep and Mkk4 would result in
stronger Bsk inactivity, resulting in degeneration phenotypes, and
that hypomorphic bsk alleles would lead to less axon degeneration
and a higher proportion of axon overextension phenotypes. Indeed,
we found that hep, Mkk double mutant clones showed a higher
frequency of axon breaks than hep or Mkk4 single mutants (Figs. 6E,
H). The number of axon breaks in hep, Mkk double mutants were
comparable to bsk-null axons (Fig. 6H; data not shown). We also
analyzed the babo gene, which when inactivated results in similar
axon overextensions (Ng, 2008). We found that babo overextended
axons had hardly any axon breaks throughout the entire neurite (data
not shown; Fig. 6H). This suggests that axon overextension does not
necessarily lead to axon breaks and neurodegeneration.
A number of bsk hypomorphic alleles were analyzed. bsk1 and bsk2
clones gave wild-type projections (data not shown). bskH15, which
carries a missense mutation in the kinase domain (Berger et al., 2008)
resulted in axon degeneration and overextension (Figs. 6F, G,
respectively). Our analysis showed while a large fraction of axons
were wild type (46.4%), 32.1% gave degeneration phenotypes, while
21.4% exhibited axon overextensions (Fig. 6I). This result shows while
the bsk-null allele results in predominantly axon degeneration,
weaker alleles do result in axon overextension, consistent with the
JNKK results.
Sustained Bsk activity is essential for axon stabilization
Is Bsk activity required throughout MB development and adult-
hood, as the phospho-JNK antibody results would suggest, or at
speciﬁc periods? This was investigated by temporally controlling Bsk
expression in two ways (Fig. 7A). First, a Bsk rescue experiment was
performed. By placing UAS-Bsk under the control of the TARGET
system (McGuire et al., 2003), raising animals at GAL4-restrictiveFig. 5. Loss of function of Hep and MKK4 in MB neurons. Representative images of
hepR39 (A), hepR75 (B) and MKK4e01458 (C, D) neuroblast clones exhibiting β lobe
axon degeneration (A), axon overextension (B, C) and cell proliferation (D)
phenotypes. Neuroblast proliferation phenotypes are characterized by the presence
of early-born γ neurons and absent later-born α'β' and αβ neurons. (E–H) hepR39
(E, F) and MKK4e01458(G, H) clones in the presence of ectopic MKK4YFP (E, H) or
Hep (F, G). Scale bars: 20 μm. Green, CD8-GFP. Magenta, Fas2. (I) Quantiﬁcation of
the β axon phenotypes. As Mkk4 leads to proliferation defects in early-born
neuroblast clones, later-born αβ neuroblast clones were generated for axon studies.
n, number of neuroblast clones analyzed.
Fig. 6. Partial inactivation of Bsk leads to axon overextension. (A, B) MB neurons expressing Bsk RNAi. High level of Bsk RNAi knockdown leads to a bias in axon degeneration
phenotypes (open arrowheads in A), whereas medium RNAi activity levels lead to dorsal axon overgrowth and medial overextensions (open arrows in B). (C) Dominant-negative
Bsk (DN Bsk) misexpression resulted in similar phenotypes. We found that pan-MB inactivation of Bsk also resulted in defasciculation defects, characterized by wider, splayed-out
axon lobes (for example, the dorsal projection in A, indicated by the open arrow). (D) Quantiﬁcation of these phenotypes. n, number of hemispheres analyzed. Given that, in many
instances, the β-lobe overextension from one hemisphere overlaps against either a similarly overextending, or otherwise wild-type, axon from the contralateral side, we also present
a different analysis of the medial projections for all (pan-MB) overexpression genotypes as the number of brains that have β-lobe overextensions over the total number of brains
analyzed (in italics next to the relevant bar). Additional analysis and quantiﬁcations for dorsal projections are in Supplementary Fig. 6. (E) Representative image of a hepR75,
MKK4e01458 mutant single-cell αβ clone. Note axon breaks in the dorsal and medial branch (open arrowheads). Similar breaks were also observed in bsk147E single-cell αβ clones
(data not shown; quantiﬁed in H). (F, G) Representative image of bskH15 neuroblast clones showing axon degeneration (F) and overextension (G) phenotypes. Cell body sections
were removed from A, C and F to clearly reveal axon projections. Scale bars: 20 μm. (H) Quantiﬁcation of axon breaks in hepR75,MKK4e01458 double, bsk147E, hepR75 orMKK4e01458 or
babo52 mutants, as indicated. Ten single-cell αβ clones were analyzed for each genotype. Statistical analysis show a signiﬁcant difference between hepR75, MKK4e01458 double or
bsk147E clones when compared to hepR75 or MKK4e01458 or babo52 mutants (Pb0.05) but no signiﬁcant difference between hepR75, MKK4e01458 double compared to bsk147E clones, or
between hepR75 andMKK4e01458 or babo52mutants (PN0.05). The only exception is in the distal axon section of hepR75 axons, where a small proportion of degeneration was observed,
as reﬂected in the P-value (0.014). babo52 clones were used as the control in the statistical study. (I) Quantiﬁcation of the bskH15 axon phenotypes in neuroblast clones, with a
comparison to the null (147E) clones.
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the timing of Bsk rescue transgene expression in bsk-null clones
(Fig. 7A and Supplementary Fig. 7; see Methods). The results are
summarized in Figs. 7B–E (quantiﬁed in F). They show that Bsk
activity is required throughout development to completely rescue the
axonal phenotypes. Shorter, latent periods of Bsk expression only
partially rescued the bsk-null phenotypes. In addition, prolonged
adult-restricted expression had very little effect.
In a second experiment, a Bsk RNAi trangene was expressed also
under TARGET control. This enabled us to perform tissue-speciﬁc
inactivation in a stage-dependent manner. We found that inducing
Bsk RNAi expression from larval (wandering L3) to late pupal (48–
96 h APF) stages resulted in axon overextension and, to a smaller
extent, axon degeneration phenotypes (Figs. 7G–J, quantiﬁed in K).
Prolonged Bsk RNAi activity restricted to the adult stage had very little
effect, suggesting that Bsk activity is dispensable in adults (Figs. 7J, K).
When expressed at shorter, later periods, these axonal phenotypes
were also not as frequent as when the Bsk RNAi was induced
throughout development. This suggests that the ‘full’ Bsk inactivation
phenotype reﬂects an accumulative period of Bsk signaling through-
out development (see Discussion).
We also performed a ‘reverse’ protocol with an early induction of
Bsk RNAi, followed by a suppression of RNAi expression from L3 or 0h
APF stages. Similar to the above treatment, this also resulted in axonal
phenotypes (Fig. 7L; data not shown). Again, the extent of these
phenotypes was not as frequent as when Bsk RNAi was induced
throughout development. Interestingly, the early treatment resulted
in more axon degenerations than overextensions, when compared to
the late induction protocol (Fig. 7J), suggesting that the degeneration
phenotype is more sensitive to an early phase of Bsk inactivity, while
the overextension phenotype is prevented more by a later phase of
Bsk.
Together these experiments suggest Bsk activity has to be sustained
throughout development to ensure proper axonal morphogenesis.
A graded AP-1 response regulates Bsk-dependent axon stability
We determined whether Bsk signals are mediated through AP-1,
which in Drosophila consists of the transcription factors Fos and Jun.
Through clonal analysis using strong, null alleles or dominant-
negative (Jbz) misexpression, Jun (also known as Jra) inactivation
alone had no effect on gross axon morphology (Jra1, n=38 clones,
Jra2, n=30 clones, Jbz, n=36 hemispheres; both 100% wild type;
Supplementary Fig. 8A,B and E, respectively). Loss-of-function
analysis on Fos (also know as kayak, or kay) was performed. These
axons appeared wild type (kay1, n=21, 100% wild type; kayED6315,
n=30, 93.3% wild type; Supplementary Fig. 7C, D), most likely
because true null alleles for kay do not exist (Giesen et al., 2003;
Weber et al., 2008). Therefore, RNAi and dominant-negative
misexpression approaches were used. Kay RNAi expression resulted
in axon overextension (Fig. 8A). In the presence of Dcr2, stronger
Kay RNAi resulted in axon degeneration phenotypes (Fig. 8B), and
this was the dominant phenotype observed (Fig. 8E). Axon over-
extensions were also observed when Fbz was misexpressed
(Fig. 8C). However, axon degeneration phenotypes were observed
when Fbz was co-expressed with Jbz (Fig. 8D; quantiﬁed in E). To
test whether these AP-1 phenotypes are linked to Bsk, we performed
genetic interaction assays by expressing Bsk RNAi together with Jbz
or Fbz (data not shown; Fig. 8F). We found that the Bsk RNAi effect
was strongly enhanced by single copy expression of Fbz, and by two
copies of Jbz.
These results suggest the AP-1 complexmediates the Bsk response
in MB neurons. These signals were similarly graded, whereby weak
AP-1 inactivation leads to axon overextension but stronger loss results
in a bias towards axon degeneration, with Kay playing the major role
in these neurons.Discussion
This study shows that the JNK pathway regulates distinct aspects
of axonal morphogenesis, namely to prevent axon overextension and
axonal degeneration. To understand the underlying differences, we
showed that the level of Bsk activity, its duration and the
developmental phase of an organism determine how developing
axons respond to these signals. The JNK signals are converted into a
transcriptional response through AP-1 and that these signals are
similarly graded in axonal morphogenesis.
The MAPK family of proteins are involved in many aspects of
cellular behavior and several hypotheses have been put forward to
account for their diverse action. Previous in vitro studies show signal
duration and signal strength can bias MAPK responses. This has been
studied mainly in the context of Erk responses towards cell
proliferation and differentiation in cultured cells (Marshall, 1995;
Murphy and Blenis, 2006). How these parameters regulate Erk signals
have been explored using experimental and theoretical approaches
(Kholodenko, 2006; Murphy and Blenis, 2006). Below we discuss the
results of this study and focus on the parameters that regulate JNK-
dependent axonal stability in vivo.
Our study explains how a single protein kinase can potentially
regulate multiple aspects of neuronal morphogenesis. Signals that
regulate Bsk activity can generate distinct axonal phenotypes
depending on the signaling network, strength and duration. The
JNKK signal network is linked to signal strength, since both JNKKs
converge on Bsk and determine its relative activity levels (Supple-
mentary Fig. 9A). In the case where the signal ensures axons do not
overextend, both Hep and Mkk4 are essential as the loss of either
input leads to axon overextension. This is phenocopied by hypomor-
phic conditions of Bsk. However, for signals that protect against
neurodegeneration and axonal loss, the JNKKs seem to act redun-
dantly, as loss of either JNKK does not result in axon degeneration,
whereas loss of Bsk, or Hep together with Mkk4 does. The bias in
responses suggest while lower levels of Bsk activity are sufﬁcient to
protect against axon degeneration, the mechanism that protects
against axon overextension requires higher threshold levels of Bsk
activity. In both cases, Bsk phosphorylation is critical for as loss of
their sites renders Bsk fully inactive.
What is currently unknown is the nature of the signal(s) that
regulate the JNK responses in these neurons, although it is likely to
be active throughout development. Also unclear is whether the
signal that protects against neurodegeneration is linked to axon
overextension, although we show overextended axons per se do not
necessarily lead to axon breaks. In one scenario, these could be
represented by distinct molecules and signaling mechanisms: one
signal acts to prevent degeneration, while another stabilizes axons at
the correct termini by preventing overextension. In a distinct
scenario, this may be one and the same factor, which acts to
promote both axon stability and termination at the correct target
site. Nonetheless, our results suggest these responses require
different Bsk threshold activities.
The phospho-JNK staining results show Bsk is active throughout
MB development and adulthood (Supplementary Fig. 9B). The genetic
results show, for axonal morphogenesis, sustained Bsk activity is
essential only throughout development, but it is not restricted to a
narrow, critical period within development. As Bsk activity (or
inactivity) during adulthood does not change the pre-existing axonal
morphology of these genotypes, this suggests JNK-dependent phys-
iology changes between development and adulthood, and the adult-
stage phospho-JNK signals most likely reﬂect a distinct mode of MB
regulation. This switch may be an example of a cell-context
requirement of JNK signaling at different developmental stages.
Although yet to be deﬁned, one possibility is an adult role in synaptic
plasticity and growth, as shown in Drosophila NMJ studies (Collins et
al., 2006; Sanyal et al., 2002).
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result in a weaker effect (as opposed to no effect at all) compared to
protocols where Bsk RNAi or rescue activity is ‘on’ throughoutdevelopment. Based on these results, we propose, for maintaining
optimal axon stability, Bsk signals are read ‘additively’ throughout
development (Supplementary Fig. 9B). Rather than as a ‘temporal
Fig. 8. A graded AP-1 signalmediates Bsk responses. (A–D)MB neurons expressing kay RNAi (A), kay RNAi plusDcr2 (B), Fbz (C), or Fbz plus Jbz (D) showed axon overextension (A, C)
and degeneration (B, D) phenotypes. Copy numbers of expressed transgenes are indicated in parenthesis. Progeny derived from Fbz and Jbz crosseswere raised at 29 °C to increase the
possibility of detecting any axonal phenotypes due tomisexpression. Scale bars: 20 μm. Green, CD8-GFP. Magenta, Fas2. (E) Quantiﬁcation of these phenotypes. In E and F, also shown
is the β-lobe overextension analysis expressed as the number of overextended brains over the total number of brains analyzed (italics). (F) Genetic interaction assay using Bsk RNAi
(line 34138) with dominant-negative AP-1. Bsk RNAi expressing ﬂies were grown at 29 °C, in presence of one copy of Fbz or two copies of Jbz, showed an enhancement in axonal
defects. As controls, Bsk RNAi ﬂies were expressed with CD8GFP alone. Single copy expression of Fbz (line 5 or 7) or two copies of Jbz (lines 1 and 10) (E) did not result in gross axon
defects. n, number of hemispheres analyzed.
75A. Rallis et al. / Developmental Biology 339 (2010) 65–77summation’ module, where signals need to reach a timed threshold
level of activity to evoke ‘all-or-none’ response, we ﬁnd the shorter
periods of Bsk activity can still derive a (albeit sub-optimal)
morphogenetic response. Nonetheless, there is still an activity
threshold required to protect against degeneration (relatively low)
and axon overextension (relatively high).Fig. 7. Sustained Bsk levels are essential for axon stability. (A) Bsk activity (as measured by
Yet the axonal phenotypes are observed only at later stages (∼30 h after puparium form
phenotypes, we used the TARGET system to determine whether the induction (+) or su
transgenic rescue analysis or RNAi at speciﬁc stages (larval, pupal or adult) alters the exte
expression under different temporal and developmental settings. (B–E) Images of bsk147ene
TARGET ﬂies raised at 29 °C (GAL4-permissive) throughout exhibited N90% wild type pro
L3 (C), and 0h APF (D). (E) bsk147eclones with Bsk-myc expression restricted only to
phenotypes. Induced at shorter periods, many ﬂies exhibited β-axon degeneration. n, num
Bsk RNAi expression induced at stages L3 (G), 0 h (H), or 96 h APF (I) resulted in axon de
adult stages for 10–20 days post-eclosion showed wild-type projections. With the exceptio
Scale bars: 20 μm. Green, CD8-GFP. Magenta, Fas2. (K) Quantiﬁcation of the Bsk TARGET
overextension analysis is also presented as the number of overextended brains over the to
time at the indicated developmental stages but rely on the ‘on’ kinetics of the TARGET s
h post-induction (Supplementary Fig. 7B–E; data not shown). Therefore, a period of RNA
transcripts and suppression of bsk-null phenotypes (respectively). (L) Quantiﬁcation of
followed by a suppression of RNAi transgene expression at L3 or 0 h APF, as indicated. No
at the early phase of Bsk inactivity.Note that in our genetic paradigm JNK activity protects against
neurodegeneration and axonal loss. In many studies, JNK activity
provokes these effects, in response to physical injury, genetic,
environmental and stress stimuli (Miller et al., 2009; Morﬁni et al.,
2006; Waetzig et al., 2006). One previous study in mutant mice
showed that JNK inactivation also leads to axonal loss. These studiesthe P-Bsk signal) is detected throughout development and adulthood (black arrow).
ation, APF) (blue arrow). To determine the temporal requirements of Bsk-dependent
ppression (−) of TARGET expression (see schematic in Supplementary Fig. 7A), by
nt of the observed phenotypes. The dashed arrows indicate the extent of the TARGET
uroblast clones with the Bsk-myc expression under TARGET control. As a control, Bsk
jections (B). bsk147eclones with Bsk-myc expression induced at developmental stages
the adult stage for 10 days post-eclosion. (F) Quantiﬁcation of these bsk rescue
ber of neuroblast clones analyzed. (G–J) Bsk RNAi expressed under TARGET control.
generation (G), and axon overextension phenotypes (H, I). (J) Bsk RNAi restricted to
n of adult-stage induced ﬂies, all earlier induced ﬂies were dissected as 3-day adults.
RNAi phenotypes. n, number of brain hemispheres analyzed. In K and L, the β-lobe
tal number of brains analyzed (italics). Note both protocols do not reﬂect a strict ‘on’
ystem. In our manipulations, we detected expression from 24 h and robustly at 72
i and Bsk-myc accumulation is required for effective downregulation of Bsk mRNA
the Bsk RNAi phenotype using a reverse TARGET protocol, with an early induction
te the increased representation of axon degeneration over overextension phenotypes
76 A. Rallis et al. / Developmental Biology 339 (2010) 65–77also showed JNK loss does not affect initial axon commissure
formation (Chang et al., 2003). Interestingly, JNK and AP-1 activity
is often upregulated in response to nerve injury and thought to be
essential for axonal repair post-injury (Herdegen et al., 1998; Raivich
et al., 2004). How our study relates to these models of disease, injury
and repair remains speculative, however, it shows parameters such as
activity levels, timing and developmental stages may be key to
understanding JNK-dependent dysfunctions in the nervous system.
Our study also raises the possibility that JNK signals are related to
developmentally regulated degenerative events such as axonal
pruning (Lee et al., 1999). However, this is unlikely, as our results
show (1) all adult bsk γ-axons exhibit only a single, medial projection
(Fig. 2J), showing that mutant axons prune properly, (2) neither is
there a delay in pruning (Figs. 2G–I), as aberrant, non-pruned, dorsal
projections are not visible at mid-pupal stages, when pruning
(followed by re-extension) has completed (Lee et al., 1999), and (3)
forced ectopic activation of the JNK pathway also does not block axon
pruning (Supplementary Fig. 10). Together these results suggest Bsk
signals (its loss or gain) does not affect developmental pruning in MB
neurons.
Our results show AP-1 signals are similarly graded to these distinct
phenotypes (Supplementary Fig. 9A). How predominantly axon-
based Bsk signals are translated into a graded, nuclear-based AP-1
transcriptional readout awaits further investigation. One can poten-
tially envisage that the different axonal behaviors derived from
graded AP-1 responses result from gene expression programs
involving separate pools of immediate early gene products, or the
same set of transcriptional targets expressed in different quantities,
and/or perhaps even under different temporal settings.
Currently, it is unclear how the Bsk/AP-1 signaling program
regulates these changes in axonal behaviors. Previous studies show
Bsk signals result in transcriptional responses involving distinct gene
targets linked to the actin cytoskeleton, cell adhesion, oxidative stress,
extracellular matrix, autophagy, cell cycle and apoptotic control
(Homsy et al., 2006; Hyun et al., 2006; Jasper et al., 2001; Moreno
et al., 2002; Uhlirova and Bohmann, 2006;Wang et al., 2003;Wu et al.,
2009). Many of these processes control Bsk-regulatedmorphogenesis.
In our preliminary analysis, we found Bsk/AP-1 signals do lead to
changes in the actin and microtubule cytoskeleton, axonal transport
and caspase-related activities (unpublished observations). These
preliminary results may be related to the axonal breaks and to
changes in the axonal architecture (such as swellings, ﬁlopodia and
lamellipodia protrusions) that were observed in bsk single-cell clones.
While we show AP-1 mechanisms are involved, it is likely that not
all of these cellular changes are AP-1 related. For example, the axonal
swellings observed in bsk clones may arise from defects in axonal
transport, which was recently reported to be perturbed in different
JNK settings (Horiuchi et al., 2007), and our preliminary results show
many of these swellings do contain an accumulation of axonal
transport cargo, such as organelles and vesicles, as measured using
mitochondrial and synaptic markers. Many AP-1-independent targets
have been reported in mammalian JNK studies and direct JNK
regulation of the actin and microtubule cytoskeleton has been
proposed (Bjorkblom et al., 2005; Chang et al., 2003; Gdalyahu
et al., 2004; Huang et al., 2003; Tararuk et al., 2006; Yoshida et al.,
2004). Currently, it is unclear how relevant these targets are in Bsk
responses in vivo. In some instances, these targets are not relevant as
either there are no obvious homologs in Drosophila (such as DCX), or
the ﬂy proteins do not have the equivalent JNK phospho-regulatory
sites (such as paxillin).
In summary, our results highlight the signaling mechanisms that
control the JNK pathway during neuronal morphogenesis. The basis of
distinct morphogenetic functions can be accounted by the graded
levels by which JNK input signals are mediated and the way AP-1
transcriptional output signals are generated, as well as the duration of
the signal propagation within developing neurons.Acknowledgments
This work was supported by the Wellcome Trust (078045). A.
Rallis was supported by a studentship from the Medical Research
Council (MRC). We thank M. Fanto, S. Guthrie, A. Ridley and O.
Schuldiner and members of the Ng lab for comments on the
manuscript. M. Bienz, D. Bohmann, M. Mlodzik, M. Ramaswami, T.
Suzuki, D. Strutt, together with the Bloomington Drosophila Stock
Center, NIG-FLY Stock Center, Vienna Drosophila RNAi Center and
DGRC, Bloomington provided critical reagents used in this study.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2009.12.016.
References
Agnes, F., Suzanne, M., Noselli, S., 1999. The Drosophila JNK pathway controls the
morphogenesis of imaginal discs during metamorphosis. Development 126,
5453–5462.
Berger, J., Senti, K.A., Senti, G., Newsome, T.P., Asling, B., Dickson, B.J., Suzuki, T., 2008.
Systematic identiﬁcation of genes that regulate neuronal wiring in the Drosophila
visual system. PLoS Genet. 4, e1000085.
Bettencourt-Dias, M., Giet, R., Sinka, R., Mazumdar, A., Lock, W.G., Balloux, F.,
Zaﬁropoulos, P.J., Yamaguchi, S., Winter, S., Carthew, R.W., Cooper, M., Jones, D.,
Frenz, L., Glover, D.M., 2004. Genome-wide survey of protein kinases required for
cell cycle progression. Nature 432, 980–987.
Bjorkblom, B., Ostman, N., Hongisto, V., Komarovski, V., Filen, J.J., Nyman, T.A., Kallunki,
T., Courtney, M.J., Coffey, E.T., 2005. Constitutively active cytoplasmic c-Jun
N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of
microtubule-associated protein 2 as an effector. J. Neurosci. 25, 6350–6361.
Bjorklund, M., Taipale, M., Varjosalo, M., Saharinen, J., Lahdenpera, J., Taipale, J., 2006.
Identiﬁcation of pathways regulating cell size and cell-cycle progression by RNAi.
Nature 439, 1009–1013.
Bosch, M., Serras, F., Martin-Blanco, E., Baguna, J., 2005. JNK signaling pathway required
for wound healing in regenerating Drosophila wing imaginal discs. Dev. Biol. 280,
73–86.
Chang, L., Jones, Y., Ellisman, M.H., Goldstein, L.S., Karin, M., 2003. JNK1 is required for
maintenance of neuronalmicrotubules and controls phosphorylation ofmicrotubule-
associated proteins. Dev. Cell 4, 521–533.
Ciapponi, L., Jackson, D.B., Mlodzik, M., Bohmann, D., 2001. Drosophila Fos mediates
ERK and JNK signals via distinct phosphorylation sites. Genes Dev. 15, 1540–1553.
Collins, C.A., Wairkar, Y.P., Johnson, S.L., DiAntonio, A., 2006. Highwire restrains
synaptic growth by attenuating a MAP kinase signal. Neuron 51, 57–69.
Delaney, J.R., Stoven, S., Uvell, H., Anderson, K.V., Engstrom, Y., Mlodzik, M., 2006.
Cooperative control of Drosophila immune responses by the JNK and NF-kappaB
signaling pathways. EMBO J. 25, 3068–3077.
Dietzl, G., Chen, D., Schnorrer, F., Su, K.C., Barinova, Y., Fellner, M., Gasser, B., Kinsey, K.,
Oppel, S., Scheiblauer, S., Couto, A., Marra, V., Keleman, K., Dickson, B.J., 2007. A
genome-wide transgenic RNAi library for conditional gene inactivation in
Drosophila. Nature 448, 151–156.
Eresh, S., Riese, J., Jackson, D.B., Bohmann, D., Bienz, M., 1997. A CREB-binding site as a
target for decapentaplegic signalling during Drosophila endoderm induction.
EMBO J. 16, 2014–2022.
Galko, M.J., Krasnow, M.A., 2004. Cellular and genetic analysis of wound healing in
Drosophila larvae. PLoS Biol. 2, E239.
Gdalyahu, A., Ghosh, I., Levy, T., Sapir, T., Sapoznik, S., Fishler, Y., Azoulai, D., Reiner, O.,
2004. DCX, a new mediator of the JNK pathway. EMBO J. 23, 823–832.
Giesen, K., Lammel, U., Langehans, D., Krukkert, K., Bunse, I., Klambt, C., 2003.
Regulation of glial cell number and differentiation by ecdysone and Fos signaling.
Mech. Dev. 120, 401–413.
Glise, B., Bourbon, H., Noselli, S., 1995. Hemipterous encodes a novel Drosophila MAP
kinase kinase, required for epithelial cell sheet movement. Cell 83, 451–461.
Han, Z.S., Enslen, H., Hu, X., Meng, X., Wu, I.H., Barrett, T., Davis, R.J., Ip, Y.T., 1998. A
conserved p38 mitogen-activated protein kinase pathway regulates Drosophila
immunity gene expression. Mol. Cell. Biol. 18, 3527–3539.
Herdegen, T., Claret, F.X., Kallunki, T., Martin-Villalba, A., Winter, C., Hunter, T., Karin,
M., 1998. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun
N-terminal kinases after neuronal injury. J. Neurosci. 18, 5124–5135.
Homsy, J.G., Jasper, H., Peralta, X.G., Wu, H., Kiehart, D.P., Bohmann, D., 2006. JNK
signaling coordinates integrin and actin functions duringDrosophila embryogenesis.
Dev. Dyn. 235, 427–434.
Horiuchi, D., Collins, C.A., Bhat, P., Barkus, R.V., Diantonio, A., Saxton, W.M., 2007.
Control of a kinesin-cargo linkage mechanism by JNK pathway kinases. Curr. Biol.
17, 1313–1317.
Huang, C., Rajfur, Z., Borchers, C., Schaller, M.D., Jacobson, K., 2003. JNK phosphorylates
paxillin and regulates cell migration. Nature 424, 219–223.
Hyun, J., Becam, I., Yanicostas, C., Bohmann, D., 2006. Control of G2/M transition by
Drosophila Fos. Mol. Cell. Biol. 26, 8293–8302.
77A. Rallis et al. / Developmental Biology 339 (2010) 65–77Ito, K., Awano, W., Suzuki, K., Hiromi, Y., Yamamoto, D., 1997. The Drosophila
mushroom body is a quadruple structure of clonal units each of which contains a
virtually identical set of neurones and glial cells. Development 124, 761–771.
Jasper, H., Benes, V., Schwager, C., Sauer, S., Clauder-Munster, S., Ansorge, W., Bohmann,
D., 2001. The genomic response of the Drosophila embryo to JNK signaling. Dev. Cell
1, 579–586.
Kholodenko, B.N., 2006. Cell-signalling dynamics in time and space. Nat. Rev. Mol. Cell
Biol. 7, 165–176.
Klueg, K.M., Alvarado, D., Muskavitch, M.A., Duffy, J.B., 2002. Creation of a GAL4/UAS-
coupled inducible gene expression system for use in Drosophila cultured cell lines.
Genesis 34, 119–122.
Kockel, L., Zeitlinger, J., Staszewski, L.M., Mlodzik, M., Bohmann, D., 1997. Jun in
Drosophila development: redundant and nonredundant functions and regulation
by two MAPK signal transduction pathways. Genes Dev. 11, 1748–1758.
Kurusu, M., Awasaki, T., Masuda-Nakagawa, L.M., Kawauchi, H., Ito, K., Furukubo-
Tokunaga, K., 2002. Embryonic and larval development of the Drosophila
mushroom bodies: concentric layer subdivisions and the role of fasciclin II.
Development 129, 409–419.
Lee, T., Luo, L., 1999. Mosaic analysis with a repressible cell marker for studies of gene
function in neuronal morphogenesis. Neuron 22, 451–461.
Lee, T., Lee, A., Luo, L., 1999. Development of the Drosophila mushroom bodies:
sequential generation of three distinct types of neurons from a neuroblast.
Development 126, 4065–4076.
Marshall, C.J., 1995. Speciﬁcity of receptor tyrosine kinase signaling: transient versus
sustained extracellular signal-regulated kinase activation. Cell 80, 179–185.
Mattila, J., Omelyanchuk, L., Kyttala, S., Turunen, H., Nokkala, S., 2005. Role of Jun
N-terminal Kinase (JNK) signaling in the wound healing and regeneration of a
Drosophila melanogaster wing imaginal disc. Int. J. Dev. Biol. 49, 391–399.
McGuire, S.E., Le, P.T., Osborn, A.J., Matsumoto, K., Davis, R.L., 2003. Spatiotemporal
rescue of memory dysfunction in Drosophila. Science 302, 1765–1768.
Miller, B.R., Press, C., Daniels, R.W., Sasaki, Y., Milbrandt, J., DiAntonio, A., 2009. A dual
leucine kinase-dependent axon self-destruction program promotes Wallerian
degeneration. Nat. Neurosci. 12, 387–389.
Moreno, E., Yan, M., Basler, K., 2002. Evolution of TNF signaling mechanisms:
JNK-dependent apoptosis triggered by Eiger, the Drosophila homolog of the TNF
superfamily. Curr. Biol. 12, 1263–1268.
Morﬁni, G., Pigino, G., Szebenyi, G., You, Y., Pollema, S., Brady, S.T., 2006. JNK mediates
pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal
transport. Nat. Neurosci. 9, 907–916.
Murphy, L.O., Blenis, J., 2006. MAPK signal speciﬁcity: the right place at the right time.
Trends Biochem. Sci. 31, 268–275.
Ng, J., 2008. TGF-beta signals regulate axonal development through distinct Smad-
independent mechanisms. Development 135, 4025–4035.
Noselli, S., 1998. JNK signaling and morphogenesis in Drosophila. Trends Genet. 14,
33–38.
Oliva Jr., A.A., Atkins, C.M., Copenagle, L., Banker, G.A., 2006. Activated c-Jun N-terminal
kinase is required for axon formation. J. Neurosci. 26, 9462–9470.
Pastor-Pareja, J.C., Grawe, F., Martin-Blanco, E., Garcia-Bellido, A., 2004. Invasive cell
behavior during Drosophila imaginal disc eversion is mediated by the JNK signaling
cascade. Dev. Cell 7, 387–399.
Pearson, J.C., Juarez, M.T., Kim, M., McGinnis, W., 2009. Multiple transcription factor
codes activate epidermal wound-response genes in Drosophila. Proc. Natl. Acad.
Sci. U. S. A. 106, 2224–2229.
Perkins, K.K., Admon, A., Patel, N., Tjian, R., 1990. The Drosophila Fos-related AP-1
protein is a developmentally regulated transcription factor. Genes Dev. 4, 822–834.
Raivich, G., Bohatschek, M., Da Costa, C., Iwata, O., Galiano, M., Hristova, M., Nateri, A.S.,
Makwana, M., Riera-Sans, L., Wolfer, D.P., Lipp, H.P., Aguzzi, A., Wagner, E.F.,
Behrens, A., 2004. The AP-1 transcription factor c-Jun is required for efﬁcient axonal
regeneration. Neuron 43, 57–67.
Ramet, M., Lanot, R., Zachary, D., Manfruelli, P., 2002. JNK signaling pathway is required
for efﬁcient wound healing in Drosophila. Dev. Biol. 241, 145–156.
Riesgo-Escovar, J.R., Hafen, E., 1997a. Common and distinct roles of DFos and DJun
during Drosophila development. Science 278, 669–672.
Riesgo-Escovar, J.R., Hafen, E., 1997b. Drosophila Jun kinase regulates expression of
decapentaplegic via the ETS-domain protein Aop and the AP-1 transcription factor
DJun during dorsal closure. Genes Dev. 11, 1717–1727.Rosso, S.B., Sussman, D., Wynshaw-Boris, A., Salinas, P.C., 2005. Wnt signaling through
Dishevelled, Rac and JNK regulates dendritic development. Nat. Neurosci. 8,
34–42.
Ryoo, H.D., Gorenc, T., Steller, H., 2004. Apoptotic cells can induce compensatory cell
proliferation through the JNK and the Wingless signaling pathways. Dev. Cell 7,
491–501.
Sanyal, S., Sandstrom, D.J., Hoeffer, C.A., Ramaswami, M., 2002. AP-1 functions upstream
of CREB to control synaptic plasticity in Drosophila. Nature 416, 870–874.
Sluss, H.K., Han, Z., Barrett, T., Goberdhan, D.C., Wilson, C., Davis, R.J., Ip, Y.T., 1996. A JNK
signal transduction pathway that mediates morphogenesis and an immune
response in Drosophila. Genes Dev. 10, 2745–2758.
Srahna, M., Leyssen, M., Choi, C.M., Fradkin, L.G., Noordermeer, J.N., Hassan, B.A., 2006. A
signaling network for patterning of neuronal connectivity in the Drosophila brain.
PLoS Biol. 4, e348.
Stronach, B., 2005. Dissecting JNK signaling, one KKKinase at a time. Dev. Dyn. 232,
575–584.
Su, Y.C., Treisman, J.E., Skolnik, E.Y., 1998. The Drosophila Ste20-related kinase
misshapen is required for embryonic dorsal closure and acts through a JNK
MAPK module on an evolutionarily conserved signaling pathway. Genes Dev. 12,
2371–2380.
Tararuk, T., Ostman, N., Li, W., Bjorkblom, B., Padzik, A., Zdrojewska, J., Hongisto, V.,
Herdegen, T., Konopka, W., Courtney, M.J., Coffey, E.T., 2006. JNK1 phosphorylation
of SCG10 determines microtubule dynamics and axodendritic length. J. Cell Biol.
173, 265–277.
Thibault, S.T., Singer, M.A., Miyazaki, W.Y., Milash, B., Dompe, N.A., Singh, C.M.,
Buchholz, R., Demsky, M., Fawcett, R., Francis-Lang, H.L., Ryner, L., Cheung, L.M.,
Chong, A., Erickson, C., Fisher, W.W., Greer, K., Hartouni, S.R., Howie, E., Jakkula, L.,
Joo, D., Killpack, K., Laufer, A., Mazzotta, J., Smith, R.D., Stevens, L.M., Stuber, C.,
Tan, L.R., Ventura, R., Woo, A., Zakrajsek, I., Zhao, L., Chen, F., Swimmer, C.,
Kopczynski, C., Duyk, G., Winberg, M.L., Margolis, J., 2004. A complementary
transposon tool kit for Drosophila melanogaster using P and piggyBac. Nat. Genet.
36, 283–287.
Uhlirova, M., Bohmann, D., 2006. JNK- and Fos-regulated Mmp1 expression cooperates
with Ras to induce invasive tumors in Drosophila. EMBO J. 25, 5294–5304.
Ventura, J.J., Hubner, A., Zhang, C., Flavell, R.A., Shokat, K.M., Davis, R.J., 2006. Chemical
genetic analysis of the time course of signal transduction by JNK. Mol. Cell 21,
701–710.
Vidal, S., Khush, R.S., Leulier, F., Tzou, P., Nakamura, M., Lemaitre, B., 2001. Mutations
in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the
control of rel/NF-kappaB-dependent innate immune responses. Genes Dev. 15,
1900–1912.
Waetzig, V., Zhao, Y., Herdegen, T., 2006. The bright side of JNKs-multitalented
mediators in neuronal sprouting, brain development and nerve ﬁber regeneration.
Prog. Neurobiol. 80, 84–97.
Wang, M.C., Bohmann, D., Jasper, H., 2003. JNK signaling confers tolerance to oxidative
stress and extends lifespan in Drosophila. Dev. Cell 5, 811–816.
Weber, U., Pataki, C., Mihaly, J., Mlodzik, M., 2008. Combinatorial signaling by the
Frizzled/PCP and Egfr pathways during planar cell polarity establishment in the
Drosophila eye. Dev. Biol. 316, 110–123.
Weston, C.R., Davis, R.J., 2002. The JNK signal transduction pathway. Curr. Opin. Genet.
Dev. 12, 14–21.
Wu, J.S., Luo, L., 2006a. A protocol for dissecting Drosophila melanogaster brains for live
imaging or immunostaining. Nat. Protoc. 1, 2110–2115.
Wu, J.S., Luo, L., 2006b. A protocol for mosaic analysis with a repressible cell marker
(MARCM) in Drosophila. Nat. Protoc. 1, 2583–2589.
Wu, H., Wang, M.C., Bohmann, D., 2009. JNK protects Drosophila from oxidative stress
by trancriptionally activating autophagy. Mech. Dev. 126, 624–637.
Yoshida, H., Hastie, C.J., McLauchlan, H., Cohen, P., Goedert, M., 2004. Phosphorylation of
microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK).
J. Neurochem. 90, 352–358.
Zeitlinger, J., Kockel, L., Peverali, F.A., Jackson, D.B., Mlodzik, M., Bohmann, D., 1997.
Defective dorsal closure and loss of epidermal decapentaplegic expression in
Drosophila fos mutants. EMBO J. 16, 7393–7401.
Zheng, X., Wang, J., Haerry, T.E., Wu, A.Y., Martin, J., O'Connor, M.B., Lee, C.H., Lee, T.,
2003. TGF-beta signaling activates steroid hormone receptor expression during
neuronal remodeling in the Drosophila brain. Cell 112, 303–315.
